Sign in

CIK 0000863894

  • Non-accelerated filer
  • Smaller reporting company
Ticker
VERU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
WI
Entity type
Operating
EIN
391144397
Phone
+1 312-595-9123
Business address
2916 N. MIAMI AVENUE, SUITE 1000, MIAMI, FL, 33127
Former names
FEMALE HEALTH CO
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market buy President and CEO bought 20,000 shares at an average $1.96 ($39,266)
  6. 4 Open-market buy Director bought 5,000 shares at $1.96 ($9,800)
  7. 4 Open-market buy Director bought 10,000 shares at $1.90 ($18,950)
  8. 4 Open-market buy Director bought 10,000 shares at $1.87 ($18,700)
  9. 4 Open-market buy President and CEO bought 10,000 shares at $1.77 ($17,709)
  10. 4 Open-market buy President and CEO bought 10,000 shares at $1.73 ($17,296)
  11. 4 Open-market buy Director bought 10,000 shares at $1.80 ($18,000)
  12. 4 Open-market buy Director bought 10,000 shares at $1.88 ($18,800)
  13. 4 Open-market buy President and CEO bought 10,000 shares at $1.82 ($18,200)
  14. 4 Open-market buy Director bought 25,000 shares at $1.75 ($43,650)
  15. 4 Open-market buy President and CEO bought 20,000 shares at $1.88 ($37,552)
  16. 4 Open-market buy Director bought 24,000 shares at $1.62 ($38,976)
  17. 4 Open-market buy President and CEO bought 20,000 shares at $1.67 ($33,438)
  18. 4 Open-market buy Director bought 20,000 shares at $1.52 ($30,328)
  19. 4 Open-market buy President and CEO bought 20,000 shares at $1.50 ($29,996)
  20. 3 Insider Initial Statement of Ownership

Page 10 of 30 · 594 filings